J&J Sees Sales Numbers Dip in Q1 2012

Johnson & Johnson announced sales of $16.1 billion for the first quarter of 2012, a decrease of 0.2% as compared to the first quarter of 2011. Operational results did increase 1%, and the negative impact of currency was 1.2%. Domestic sales declined 5.1%, while international sales increased 4.1%, reflecting operational growth of 6.4% and a negative currency impact of 2.3%.

The company did report its Neutrogena brand contributed positively to operational results for its Worldwide Consumer division sales, which came in at $3.6 billion for the first quarter. International sales of oral care products also were strong, but the division’s sales numbers represented a decrease of 2.4% versus the prior year consisting of an operational decline of 0.6% and a negative impact from currency of 1.8%. Domestic sales decreased 2.2%, and international sales decreased 2.5%, which reflected an operational increase of 0.4% and a negative currency impact of 2.9%.

“We continue to bring meaningful innovations to our customers through the strong performance of our recently launched products,” said William C. Weldon, J&J chairman and CEO. “The dedication of the people of Johnson & Johnson gives me great confidence in the prospects of our business to deliver sustainable growth well into the future.”

Additional information on this financial report is available here.

More in News